AAM Calls For A Balance Instead Of Banning Pay-For-Delay
As Biden’s Executive Order Asks FTC To Scrap Pay-For-Delay And Similar Deals
US President Joe Biden has signed an executive order asking the FTC to ban so-called “pay-for-delay” reverse-payment settlements. According to the order, this could help curb high prices that are in part the result of lack of competition among drug manufacturers. However, talking exclusively to Generics Bulletin, AAM senior vice president Jeff Francer insists on a balance, explaining that such settlements result in earlier access to biosimilars and generics.
